ASX-listed authentication company Dotz Nano (ASX:DTZ) has secured a new distributor for its SARS-CoV-2 virus detection technology, signing a three-year agreement with ScienceVision Sdn Bhd in Malaysia.
ScienceVision is one of Malaysia’s leading providers of end-to-end scientific solutions with established relationships across government, private organisations and academic institutes. It is currently the exclusive distributor in Malaysia of reputable brands such as Illumina and Genefix.
Effective immediately, the distribution agreement grants ScienceVision the right to sell the Dotz Test Kits in Malaysia with conditional exclusivity subject to minimum first-year purchase orders of US$600,000. The agreement provides for its automatic renewal for additional one-year periods on a non-exclusive basis.
ScienceVision is Dotz’s third distributor for its SARS-CoV-2 virus detection technology, following recent distribution agreements with El Alamo and Hygiene Links covering Paraguay, Egypt, Sudan and the UAE.
Dotz’s end-to-end SARS-CoV-2 virus detection technology can simultaneously test up to 96 samples per device with results delivered on-site in approximately 30 minutes. Results are evidenced by a visual change in the colour of samples, ensuring a simple and rapid analysis procedure.
Dotz has obtained a CE Mark for both its nasopharyngeal swab and saliva-based Dotz Test Kits, which clears the product for sale in the European Union. Dotz has also applied for a US FDA Emergency Use Authorisation, following a successful blind clinical trial of the nasopharyngeal swab Dotz Test Kits on 73 subjects in the US.
Dotz CEO Gideon Shmuel said, “As travel restrictions ease globally, the need to accurately and quickly test for SARS-CoV-2 becomes paramount. Our SARS-CoV-2 virus detection technology is ideal for countries that are heavily dependent on tourism, providing a cost-effective and timely testing method. This new distribution agreement provides us with a foothold in Malaysia at a time when it is reopening to tourists for the first time in 18 months. Our saliva-based Dotz Test Kits are significantly less invasive than standard nasopharyngeal swab tests, and are suitable for young children.
“Dotz remains focused on commercialising its diagnostic technology, and we have a large, global market opportunity. ScienceVision is an established and reputable distributor in Malaysia, enabling Dotz to leverage its established sales channels and customer networks.”